Lepu Medical Stock Hits Day Low of CNY 12.58 Amid Price Pressure

Lepu Medical Technology (Beijing) Co., Ltd. experienced a notable decline today, with the stock dropping by 5.27% and reaching an intraday low of CNY 12.58. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past week, Lepu Medical has shown a slight recovery with a 2.28% increase, although its one-year performance remains negative at -16.3%. The company has faced consistent challenges, reflected in its long-term growth metrics, including a net sales decline of 6.74% annually and a significant drop in operating profit by 14.39% over the last five years. Financial indicators reveal a low interest coverage ratio of 258.35 and a pre-tax profit of CNY 259.97 million, which has decreased by 41.49%. Despite these challenges, Lepu Medical maintains a return on equity of 5.26% and a price-to-book ratio of 1.15, indicating a potentially attractive valuation. The company also offers a dividend yield of 2.96%, providing some return to shareholders amidst its recent performance struggles.